{"filing":{"accession_number":"0001437749-26-024693","cik":"0001520697","ticker":"ACHC","company_name":"Acadia Healthcare Company, Inc.","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"achc20260728c_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1520697/000143774926024693/achc20260728c_8k.htm"},"events":[{"id":21195,"run_id":19105,"accession_number":"0001437749-26-024693","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Acadia Healthcare disclosed second quarter 2026 financial results, reporting revenue of $865.8 million, net income of $10.9 million ($0.12 per diluted share), and Adjusted EBITDA of $149.2 million, along with updated full-year 2026 guidance. The company also announced a conference call to discuss these results.","company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20764,"accession_number":"0001437749-26-024693","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Acadia Healthcare's second quarter 2026 financial results, including revenue of $865.8 million, net income of $10.9 million ($0.12 per diluted share), and Adjusted EBITDA of $149.2 million, along with updated full-year 2026 guidance. The press release is furnished as Exhibit 99.1 and is the primary disclosure under Item 2.02 (Results of Operations and Financial Condition).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T00:00:43.202665+00:00","company_name":"","ticker":null,"filing_date":""},{"id":20765,"accession_number":"0001437749-26-024693","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure announces a conference call to discuss Acadia's second quarter 2026 financial results, with Exhibit 99.1 containing the full earnings release showing Q2 2026 revenue of $865.8 million, net income of $10.9 million ($0.12 per diluted share), and updated full-year 2026 guidance. This is a standard earnings release disclosure material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T00:00:43.202665+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20764,"accession_number":"0001437749-26-024693","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Acadia Healthcare's second quarter 2026 financial results, including revenue of $865.8 million, net income of $10.9 million ($0.12 per diluted share), and Adjusted EBITDA of $149.2 million, along with updated full-year 2026 guidance. The press release is furnished as Exhibit 99.1 and is the primary disclosure under Item 2.02 (Results of Operations and Financial Condition).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T00:00:43.202665+00:00","company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","filing_date":"2026-07-28"},{"id":20765,"accession_number":"0001437749-26-024693","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure announces a conference call to discuss Acadia's second quarter 2026 financial results, with Exhibit 99.1 containing the full earnings release showing Q2 2026 revenue of $865.8 million, net income of $10.9 million ($0.12 per diluted share), and updated full-year 2026 guidance. This is a standard earnings release disclosure material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T00:00:43.202665+00:00","company_name":"Acadia Healthcare Company, Inc.","ticker":"ACHC","filing_date":"2026-07-28"}]}